Uji klinis Kejang di Alabama
8 studi untuk Kejang mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 3
Usia 2 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04462770Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
- Clinic for Neurology, Huntsville
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT07594119Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectations as Targets of a Treatment for PNES
- Sparks Center Office of Psychiatric Research, Birmingham
Menerima pesertaSukarelawan sehat diterima
Usia 11 hingga 18 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT05096273Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
- University of Alabama at Birmingham, Birmingham
Menerima pesertaStudi observasionalMenyebutkan pembayaran untuk peserta
Usia 8 hingga 89 · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06362161Retraining and Control Therapy (ReACT)- Adults
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 11 Jun 2026 · NCT06570954Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- University of Alabama, Birmingham
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT05135091Retraining and Control Therapy (ReACT) R33 Phase
- University of Alabama at Birmingham, Birmingham
Menerima pesertaSukarelawan sehat diterima
Usia 11 hingga 18 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06007053A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 11 hingga 18 · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT05819268Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.